| Recruitment status | Open public recruiting |
| Unique ID issued by UMIN | UMIN000030755 |
| Receipt No. | R000035113 |
| Official scientific title of the study | Analysis of sarcopenia in patients with liver disorder |
| Date of disclosure of the study information | 2018/01/10 |
| Last modified on | 2018/01/10 (Ver. 1) |
| Basic information | ||
| Official scientific title of the study | Analysis of sarcopenia in patients with liver disorder |
|
| Title of the study (Brief title) | sarcopenia in patients with liver disorder |
|
| Region |
|
|
| Condition | ||
| Condition | Patients with liver disorder | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To analyze the frequency and the associated factors of sarcopenia in patients with liver order |
| Basic objectives2 | Others |
| Basic objectives -Others | To analyze the frequency and the associated factors of sarcopenia in patients with liver order |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | To investigate Frequency of sarcopenia in Patients with liver disorder |
| Key secondary outcomes | 1To investigate association between PMI and Body composition analysis 2 To investigate cause of liver disease in patients with Sarcopenia 3 To investigate the effects of BCAA, carnitine and diuretic drug administration on sacropenia |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1 patients with liver disorder 2 20 year old or more than 20 years old 3 patients who agree to paticipate this study or disagree to paticipate this study. |
|||
| Key exclusion criteria | patients judged to be inappropriate to participate in the study by the primary physician | |||
| Target sample size | 1000 | |||
| Research contact person | |
| Name of lead principal investigator | Koji Ogawa |
| Organization | Graduate School of Medicine, Hokkaido University |
| Division name | Department of Gastroenterology and Hepatology |
| Address | North 15, West 7, Kita-ku, Sapporo, Hokkaido |
| TEL | 011-716-2111 |
| k-ogawa@med.hokudai.ac.jp | |
| Public contact | |
| Name of contact person | Goki Suda |
| Organization | Graduate School of Medicine, Hokkaido University |
| Division name | Department of Gastroenterology and Hepatology |
| Address | North 15, West 7, Kita-ku, Sapporo, Hokkaido |
| TEL | +81-11-716-1161 |
| Homepage URL | |
| gsudgast@pop.med.hokudai.ac.jp | |
| Sponsor | |
| Institute | Hokkaido University, Department of Gastroenterology and Hepatology |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Hokkaido University, Department of Gastroenterology and Hepatology |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Open public recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | 1 clinical factors (age, sex, hight, weight, BCAA administration, carnitine administration,presence of HCC, presence of ascites fluid e.g.) 2 blood count 3 biochemical examination (T-bil, Alb,AST,ALT,GTP,ALP,TP,LDH,Cr,BUN,Na,K,Cl,IGF-1,VitaminD PT% e.g.) 4 amount of skeltal muscle mass |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000035113 |